4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-008663
Chief Scientific Officer sold 100,000 shares at $27.37 ($2,737,470)
- Chief Scientific Officer acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Russell Alan J · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +100,000 | $0.18 | $18,000 | 114,863 | D |
| 2024-12-30 | Sale : show line 2 in the form 10b5-1 | −100,000 | $27.37 | $2,737,470 | 14,863 | D |
| Open-market sales · 100,000 sh · avg $27.37 · $2,737,470 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −100,000 | 1,356,780 | D |
Loading xslF345X05/primarydocument.xml…